London; United Kingdom
Aglaris is developing an automated cell culture bioreactor for the mass production of human stem cells. Aglaris Cell stems from the collaboration between researchers at two institutions, the biomaterials group at Barcelona’s IQS and the group for the Regulation of the Genetic Expression and Stability of Stem Cells at a leading organization.
BioMediTech, a joint institute of Tampere University of Technology and University of Tampere, brings together a powerful mix of multidisciplinary expertise in life sciences and medical technology. Over 250 scientists conduct research and education in the fields of cell and molecular biology, genetics, biomaterials, biosensors, computational systems, biotechnology, biomedical engineering, and regenerative medicine.
Campania Bioscience Scarl
Campania Bioscience is a regional cluster set in Naples (Campania region – Southern Italy) gathering together competences and facilities in the fields of Health, Biotech and Agro-food, with the aim of valorising partners’ expertise in the value chain, stimulating exploitation of cluster assets, supporting knowledge transfer and encouraging international networking and partnerships.
China Bioengineering Technology Group Ltd
China Bioengineering Technology Group Limited (CBT) is located in Hong Kong Science Park. It is a high-tech professional body comprising of biomedical science, precision medicine, as well as big data access, statistics and analysis. Our company possesses the independent intellectual property right for gene testing technology and platform for biomedical data analysis?including the patent for genetic testing and copyright for genetic testing software.
OnTarget Chemistry – was established, initially as OncoTargeting, in 2008 as a spin-out from the medicinal chemistry, combinatorial chemistry and preclinical analysis departments of Pharmacia (Biovitrum). We have continued to employ some of the industry’s most experienced chemists and run a well-trimmed organization with solid values of service, quality and efficiency.
OP2 Drugs SAS ("OP2")
OP2 Drugs SAS ("OP2") is a biotech company that aims at developing innovative life-saving drugs for unmet medical needs, especially in the cardiology field. Our first patented compound, OP2113, which targets mitochondrial dysfunction, is in preclinical stage, with a strong scientific rational.
Liverpool, United Kingdom
Redx Pharma has quickly established itself as one of the largest biotechnology companies in Europe, focused on the development of a wide range of early stage, proprietary small molecule therapeutics to address high unmet medical needs in cancer and infectious disease.
University of Birmingham
Birmingham; United Kingdom
Birmingham is constantly developing and evolving in its desire to become a leading global university. This is being achieved through the enhanced research power and reach; the distinctiveness of exceptional student experience; the breadth and depth of academic portfolio; size and extent of the global networks.